UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 550

Sortiert nach

Safety and Efficacy of a Combination of Imatinib and Pegylated Interferon α2a (Pegasys®) in Newly Diagnosed Patients with Chronic Myelogenous Leukemia - A Phase II Cohort Study

Blood, 2007-11, Vol.110 (11), p.1027-1027

2007

Volltextzugriff (PDF)

Efficacy and Safety of Bosutinib (SKI-606) among Patients with Chronic Phase Ph+ Chronic Myelogenous Leukemia (CML)

Blood, 2007-11, Vol.110 (11), p.733-733

2007

Volltextzugriff (PDF)

Bosutinib (SKI-606) Demonstrates Clinical Activity and Is Well Tolerated among Patients with AP and BP CML and Ph+ ALL

Blood, 2007-11, Vol.110 (11), p.473-473

2007

Volltextzugriff (PDF)

Erythrocyte deformation under shear flow [letter]

Blood, 1989-03, Vol.73 (4), p.1074-1075

Fischer, TM

1989

Volltextzugriff (PDF)

Results of a Multicenter Phase II Trial for Older Patients with c-Kit Positive Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS) Using Low-Dose Ara-C (LDAC) and Imatinib

Blood, 2005-11, Vol.106 (11), p.1853-1853

2005

Volltextzugriff (PDF)

Durable Molecular Remissions in Patients with Relapsed CML Post Allogeneic Stem Cell Transplantation upon Treatment with Imatinib-Mesylate (Glivec®, STI-571). Follow-Up Results of a Phase II Open-Label Study

Blood, 2004-11, Vol.104 (11), p.1004-1004

2004

Volltextzugriff (PDF)

Phase 1 Study of PKC412, an Oral FLT3 Kinase Inhibitor, in Sequential and Concomitant Combinations with Daunorubicin and Cytarabine (DA) Induction and High-Dose Cytarabine (HDAra-C) Consolidation in Newly Diagnosed Patients with AML

Blood, 2004-11, Vol.104 (11), p.262-262

2004

Volltextzugriff (PDF)

Mechanisms of Resistance to the FLT3-Tyrosine Kinase Inhibitor PKC412 in Patients with AML

Blood, 2004-11, Vol.104 (11), p.454-454

2004

Volltextzugriff (PDF)

Clinical Course and Significance of the Novel FLT3-Y842C Mutation in a Patient with AML Treated with PKC412 Monotherapy

Blood, 2004-11, Vol.104 (11), p.2537-2537

2004

Volltextzugriff (PDF)

The Role of Adult Cancer Predisposition Genes in Hematological Malignancies of Childhood

Blood, 2022-11, Vol.140 (Supplement 1), p.8750-8751

2022

Volltextzugriff (PDF)

Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins

Blood, 2007-06, Vol.109 (12), p.5494-5501

2007

Volltextzugriff (PDF)

Primary T Cell Immunodeficiencies and Autoimmunity

Blood, 2011-11, Vol.118 (21), p.SCI-21-SCI-21

Fischer, Alain

2011

Volltextzugriff (PDF)

The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in ≈0.6% of healthy newborns

Blood, 2019-10, Vol.134 (16), p.1355-1358

2019

Volltextzugriff (PDF)

Genome-wide screen identifies cullin-RING ligase machinery required for lenalidomide-dependent CRL4CRBN activity

Blood, 2018-09, Vol.132 (12), p.1293-1303

2018

Volltextzugriff (PDF)

Differential expression of Plg-RKT and its effects on migration of proinflammatory monocyte and macrophage subsets

Blood, 2019-08, Vol.134 (6), p.561-567

2019

Volltextzugriff (PDF)

Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity and life-threatening complications: an international retrospective matched pairs analysis

Blood, 2023-01

2023

Volltextzugriff (PDF)

Comparison of Clinical Features and Outcomes in Patients with Primary Central Nervous System Lymphoma Treated within and Outside a Clinical Trial: A Retrospective Study

Blood, 2017-12, Vol.130, p.1565-1565

2017

Volltextzugriff (PDF)

Family Trio-Based Whole Genome Optical Mapping Identifies Candidate Structural Variations Predisposing Children to Acute Lymphoblastic Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.5201-5201

2019

Volltextzugriff (PDF)

Trends in Iron Overload over Past Two Decades: Results from the Natural History of Iron Burden Study with the SQUID Biosusceptometer

Blood, 2019-11, Vol.134 (Supplement_1), p.961-961

2019

Volltextzugriff (PDF)

Reveal the Neutrophil: Elucidating the Role of a Neutrophil-Specific JAK2-V617F Mutation

Blood, 2019-11, Vol.134 (Supplement_1), p.2965-2965

2019

Volltextzugriff (PDF)

Resolving Interference of Direct Oral Anticoagulants (DOACs) on Routine Coagulation, Thrombophilia, and Lupus Anticoagulant Testing Using Activated Carbon

Blood, 2021-11, Vol.138 (Supplement 1), p.830-830

2021

Volltextzugriff (PDF)

The Emicizumab Switch: Real-World Data of 251 Pediatric Patients from the Pednet Registry

Blood, 2022-11, Vol.140 (Supplement 1), p.8442-8443

2022

Volltextzugriff (PDF)

IFN-Gamma Is Crucial for the Counterbalance of T Cell-Mediated Injury to the Intestinal Stem Cell Compartment By Regulatory T Cells in Mice and Humans

Blood, 2022-11, Vol.140 (Supplement 1), p.10223-10224

2022

Volltextzugriff (PDF)

1 – 25 von 550

Suche als RSS-Feed

Aktive Filter

PublikationsformBilder

ThemaScience & Technology

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(550)
Mit Volltextzugriff
(549)

Publikationsform

Artikel
(550)

Sprache

Englisch
(550)
Japanisch
(9)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

Safety and Efficacy of a Combination of Imatinib and Pegylated Interferon α2a (Pegasys®) in Newly Diagnosed Patients with Chronic Myelogenous Leukemia - A Phase II Cohort Study

Efficacy and Safety of Bosutinib (SKI-606) among Patients with Chronic Phase Ph+ Chronic Myelogenous Leukemia (CML)

Bosutinib (SKI-606) Demonstrates Clinical Activity and Is Well Tolerated among Patients with AP and BP CML and Ph+ ALL

Erythrocyte deformation under shear flow [letter]

Results of a Multicenter Phase II Trial for Older Patients with c-Kit Positive Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS) Using Low-Dose Ara-C (LDAC) and Imatinib

Durable Molecular Remissions in Patients with Relapsed CML Post Allogeneic Stem Cell Transplantation upon Treatment with Imatinib-Mesylate (Glivec®, STI-571). Follow-Up Results of a Phase II Open-Label Study

Phase 1 Study of PKC412, an Oral FLT3 Kinase Inhibitor, in Sequential and Concomitant Combinations with Daunorubicin and Cytarabine (DA) Induction and High-Dose Cytarabine (HDAra-C) Consolidation in Newly Diagnosed Patients with AML

Mechanisms of Resistance to the FLT3-Tyrosine Kinase Inhibitor PKC412 in Patients with AML

Clinical Course and Significance of the Novel FLT3-Y842C Mutation in a Patient with AML Treated with PKC412 Monotherapy

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

The Role of Adult Cancer Predisposition Genes in Hematological Malignancies of Childhood

Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins

Primary T Cell Immunodeficiencies and Autoimmunity

The preleukemic TCF3-PBX1 gene fusion can be generated in utero and is present in ≈0.6% of healthy newborns

Genome-wide screen identifies cullin-RING ligase machinery required for lenalidomide-dependent CRL4CRBN activity

Differential expression of Plg-RKT and its effects on migration of proinflammatory monocyte and macrophage subsets

Allogeneic stem cell transplantation compared to conservative management in adults with inborn errors of immunity and life-threatening complications: an international retrospective matched pairs analysis

Comparison of Clinical Features and Outcomes in Patients with Primary Central Nervous System Lymphoma Treated within and Outside a Clinical Trial: A Retrospective Study

PLCG1 is required for AML1-ETO leukemia stem cell self-renewal

Family Trio-Based Whole Genome Optical Mapping Identifies Candidate Structural Variations Predisposing Children to Acute Lymphoblastic Leukemia

Trends in Iron Overload over Past Two Decades: Results from the Natural History of Iron Burden Study with the SQUID Biosusceptometer

Reveal the Neutrophil: Elucidating the Role of a Neutrophil-Specific JAK2-V617F Mutation

Resolving Interference of Direct Oral Anticoagulants (DOACs) on Routine Coagulation, Thrombophilia, and Lupus Anticoagulant Testing Using Activated Carbon

The Emicizumab Switch: Real-World Data of 251 Pediatric Patients from the Pednet Registry

IFN-Gamma Is Crucial for the Counterbalance of T Cell-Mediated Injury to the Intestinal Stem Cell Compartment By Regulatory T Cells in Mice and Humans

Aktive Filter

Suchergebnisse filtern